摘要
KLF14作为转录因子中的一员,能与靶基因序列进行特异性的结合,调控靶基因的转录,参与人体生理和病理过程。目前研究发现KLF14在脂肪组织中发挥重要的作用,参与动脉粥样硬化和2型糖尿病疾病的进展,除此之外,作为肿瘤抑制因子参与肿瘤的发生发展。
As one of the transcription factors,KLF14 can specifically bind to target gene sequences,regulate the transcription of target genes,and participate in human physiological and pathological processes.At present,KLF14 plays an important role in adipose tissue,and participates in the progression of atherosclerosis and type 2 diabetes diseases.In addition,it participates in tumor development as a tumor suppressor.
作者
侯玉丽(综述)
王培昌(审校)
HOU Yuli;Wang Peichang(Department of Clinical Laboratory,Xuanwu Hospital of Capital Medical University,Beijing 10053,China)
出处
《国际检验医学杂志》
CAS
2020年第11期1395-1398,共4页
International Journal of Laboratory Medicine
基金
国家自然科学基金项目(81871714,81472007)
北京市医管局人才培养计划“登峰”基金项目(DFL20180803)。